search
Back to results

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

Primary Purpose

Dry Eye

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Liposic
Tears Naturale Forte
Sponsored by
Sun Yat-sen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dry Eye focused on measuring Tear film, Lipid layer, Liposic, Tears Naturale Forte

Eligibility Criteria

20 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Minimum age of 20 years(range from 20 year to 25 years)
  • The value of OSDI is over 12
  • NBUT is less 5 seconds
  • Schirmer 1 test is less 10mm
  • The basical lipid layer grade is 1-2

Exclusion Criteria:

  • Any corneal,conjunctival, or eyelid abnormalities; conjunctivitis; current ocular infection; photophobia that may cause reflex tearing or difficulty in evaluating the patient's lipid layer;
  • Known allergic sensitivity to any of the ingredients in Liposic or Tears Naturale Forte

Sites / Locations

  • Hainan Eye Hospital, Zhongshan Ophthalmic Center of Sun Yat-sen UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Liposic

Tears Naturale Forte

Arm Description

Liposic was applied to one eye of patients in this group

Tears Naturale Forte was applied to one eye of patients in this group

Outcomes

Primary Outcome Measures

scale of Schirmer I test
scale of corneal fluorescein staining
scale of noninvasive tear breakup time
scale of tear meniscus height
lipid layer grade
questionnaire of ocular surface disease index

Secondary Outcome Measures

subjective comfort
Subjective comfort was established at each time-point by asking subjects, firstly, to relate their comfort to baseline in each eye (more comfortable/no different/less comfortable) . secondly, to express a preference for their more comfortable eye (right eye/left eye/no difference)

Full Information

First Posted
December 12, 2016
Last Updated
December 14, 2016
Sponsor
Sun Yat-sen University
search

1. Study Identification

Unique Protocol Identification Number
NCT02992392
Brief Title
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
Official Title
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
December 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
May 2017 (Anticipated)
Study Completion Date
June 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sun Yat-sen University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte application on the lipid and stability of the tear film in dry eye patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dry Eye
Keywords
Tear film, Lipid layer, Liposic, Tears Naturale Forte

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Liposic
Arm Type
Experimental
Arm Description
Liposic was applied to one eye of patients in this group
Arm Title
Tears Naturale Forte
Arm Type
Experimental
Arm Description
Tears Naturale Forte was applied to one eye of patients in this group
Intervention Type
Drug
Intervention Name(s)
Liposic
Other Intervention Name(s)
Carbomer
Intervention Description
one eye of the participant recieved Lipoic
Intervention Type
Drug
Intervention Name(s)
Tears Naturale Forte
Other Intervention Name(s)
DEXTRAN/HYPROMELLOSE/GLYCERIN
Intervention Description
the other eye of the participant recieved Tears Naturale Forte
Primary Outcome Measure Information:
Title
scale of Schirmer I test
Time Frame
up to 3 months after tear substitutes apply
Title
scale of corneal fluorescein staining
Time Frame
up to 3 months after tear substitutes apply
Title
scale of noninvasive tear breakup time
Time Frame
up to 3 months after tear substitutes apply
Title
scale of tear meniscus height
Time Frame
up to 3 months after tear substitutes apply
Title
lipid layer grade
Time Frame
up to 3 months after tear substitutes apply
Title
questionnaire of ocular surface disease index
Time Frame
up to 3 months after tear substitutes apply
Secondary Outcome Measure Information:
Title
subjective comfort
Description
Subjective comfort was established at each time-point by asking subjects, firstly, to relate their comfort to baseline in each eye (more comfortable/no different/less comfortable) . secondly, to express a preference for their more comfortable eye (right eye/left eye/no difference)
Time Frame
up to 3 months after tear substitutes apply

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Minimum age of 20 years(range from 20 year to 25 years) The value of OSDI is over 12 NBUT is less 5 seconds Schirmer 1 test is less 10mm The basical lipid layer grade is 1-2 Exclusion Criteria: Any corneal,conjunctival, or eyelid abnormalities; conjunctivitis; current ocular infection; photophobia that may cause reflex tearing or difficulty in evaluating the patient's lipid layer; Known allergic sensitivity to any of the ingredients in Liposic or Tears Naturale Forte
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chi Zhang, MD,PhD
Email
mike0946@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xingwu Zhong
Organizational Affiliation
Zhongshan Ophthalmic Center, Sun Yat-sen University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hainan Eye Hospital, Zhongshan Ophthalmic Center of Sun Yat-sen University
City
Haikou
State/Province
Hainan
ZIP/Postal Code
570311
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xingwu Zhong, MD,PhD
Phone
+86(898)68628481
Email
zhongxwu@mail.sysu.edu.cn

12. IPD Sharing Statement

Learn more about this trial

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

We'll reach out to this number within 24 hrs